Tuesday, September 8, 2015
Cepheid, a Sunnyvale, Calif.-based molecular diagnostics company, FIND, a Switzerland-based international nonprofit organization and Rutgers New Jersey Medical School are collaborating to develop Xpert MTB/RIF Ultra, a next-generation test for Mycobacterium tuberculosis (TB) with increased sensitivity to aid in detection of patients with smear-negative TB, which often is associated with HIV co-infection. The collaboration also is receiving additional support from the National Institute of Allergy and Infectious Diseases at the NIH.
The National Institute of Allergy and Infectious Diseases (NIAID) of the NIH has selected infectious disease expert David Perlin, executive director of the Public Health Research Institute at Rutgers New Jersey Medical School, to lead a major research effort aimed at developing new forms of antibiotics to regain the upper hand over deadly bacteria that have become resistant to current treatments.
Life Technologies, a global biotechnology company, has announced five Innovation Grant recipients in the Digital PCR Applications Grant Program during the American Society for Human Genetics (ASHG) conference in Boston. Each will receive a QuantStudio 3D Digital PCR System for research projects that demonstrate innovative applications in digital PCR.
Watson Pharmaceuticals is planning a global R&D technology center in North Brunswick, N.J. The company has signed a lease for a 32,000-square-foot facility at the Economic Development Authority’s Technology Center of New Jersey, a 50-acre complex consisting of lab, production and office space. Watson intends to initially invest approximately $4.5 million in outfitting the new facility.
Clinical Trials and Surveys Corp (C-TASC), a clinical trials solutions company, hired three new biostatisticians and plans to double its staff in the next year. The company, which currently employs 35 people, plans to increase to 60 employees by February 2010 in order to keep up with increased demand for its clinical trial services and technologies.